Turkey
Iontek Molecular Diagnostics, founded in 1997, stands out as a trailblazer in the molecular diagnostics sector within Turkey. Renowned for its commitment to quality, Iontek operates under stringent standards such as ISO 9001: 2015 and ISO 13485: 2016, ensuring high-quality outcomes in their molecular diagnostic tests and services.
The company's innovative use of real-time PCR technology in the diagnosis and monitoring of viral diseases, including Hepatitis B, C, D and HIV, highlights its technological expertise. Iontek offers a wide array of certified test kits and personalized solutions, effectively catering to more than 100 laboratories.
Empowered by over two decades of experience, Iontek collaborates actively with education initiatives, research centers, and private hospitals. This positions it as a formidable entity in the Digital Health, Health Care, and Life Sciences industries. Despite a lack of recent investment information, its long-term dedication to innovation and customer-oriented strategy underscores significant potential for real impact within healthcare.
